The chemistry and biological profile of trovafloxacin
Authors:
- T. D. GootzTGT. D. Gootz
Open Access
- 1 June 1997
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 39 (suppl 2) , 1-14
Abstract
The fluoroquinolone antibacterials are noted for their activity after oral administration and potent activity against Gram-negative pathogens. Trovafloxacin (CP-99,219) is a new quinolone antibacterial characterized by a novel 3-azabicyclo[3.1.0]hexyl substituent at the C-7 position, which was discovered in the course of a programme targeting improved activity compared with ciprofloxacin against Gram-positive aerobic organisms and anaerobes, as well as an extended elimination half-life. An overview of the chemical properties of trovafloxacin is given. Trovafloxacin exhibits excellent potency against Gram-positive organisms and anaerobes, while retaining the potent Gram-negative activity of ciprofloxacin. Its pharmacokinetic properties in humans have been shown to be compatible with a once-daily dosing regimen. The combined spectrum and pharmacokinetics of trovafloxacin have been demonstrated to result in excellent efficacy in both animal models of infections and human clinical trials. Phase II and Phase III programmes have been completed.Keywords
This publication has 42 references indexed in Scilit:
- Fluoroquinolone antibacterials: SAR, mechanism of action, resistance, and clinical aspectsMedicinal Research Reviews, 1996
- In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Determination of trovafloxacin, a new quinolone antibiotic, in biological samples by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- The Complex of DNA Gyrase and Quinolone Drugs with DNA Forms a Barrier to Transcription by RNA PolymeraseJournal of Molecular Biology, 1994
- The Biochemistry and Biology of DNA Gyrase1994
- Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions.Journal of Biological Chemistry, 1993
- Pharmacokinetics of Gyrase Inhibitors, Part 1: Basic Chemistry and Gastrointestinal DispositionThe American Journal of Medicine, 1993
- The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environmentEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- New topoisomerase essential for chromosome segregation in E. coliCell, 1990
- Aqueous solubilities of some variously substituted quinolone antimicrobialsInternational Journal of Pharmaceutics, 1990